Combination therapy with 5-fluorouracil (nsc-19893), mitomycin C (nsc-26980), vincristine (nsc-67574), and thiotepa (nsc-6396) for advanced cancer.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents